Drawing for CLARIVANT

USPTO serial 99121313

CLARIVANT

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLARIVANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joyce M. Ferraro

Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of pharmaceutical and medical research and clinical trials; providing information management services and management and compilation of computerized databases in the field of pharmaceutical and medical research and clinical trialsACTIVE—
042Monitoring, reviewing and analyzing pharmaceutical and medical research data; providing pharmaceutical, medical and scientific research information in the field of clinical trials; design, planning and implementation project management in the field of pharmaceutical and medical research and clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 19, 2025MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Jun 19, 2025ABN1ABANDONMENT - EXPRESS MAILED—
Jun 18, 2025EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Apr 4, 2025NWAPNEW APPLICATION ENTERED—
Apr 4, 2025MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance